[EN] GPR52 MODULATOR COMPOUNDS<br/>[FR] COMPOSÉS MODULATEURS DE GPR52
申请人:HEPTARES THERAPEUTICS LTD
公开号:WO2021181122A1
公开(公告)日:2021-09-16
The disclosures herein relate to novel compounds of Formula (1): and salts thereof, wherein X, Y, R1, R2, R3 and R4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR52 receptors.